Cargo Therapeutics IPO

Cargo Therapeutics is a biotechnology company that specializes in developing precision therapeutics for cancer treatment. Their proprietary technology platform enables the targeted delivery of small molecules and biologics to cancer cells, while minimizing off-target effects on healthy cells. The company's lead product candidate, CT-100, is a novel therapeutic that selectively targets cancer cells expressing the protein EphA2, which is overexpressed in a variety of solid tumors. Cargo Therapeutics aims to improve patient outcomes and reduce the toxicity of cancer treatments with their precision therapeutics.

Register for Details

For more details on financing and valuation for Cargo Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Cargo Therapeutics's ticker symbol?

Cargo Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Cargo Therapeutics's stock price?

The stock price for Cargo Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Cargo Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
7/31/2023 Series A-1 $86.04MM raised $XXX.XX $XXX.XX
12/9/2022 Series A-2 $34.42MM raised $XXX.XX $XXX.XX
4/26/2022 Series Seed $11MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Cargo Therapeutics

Forge green plus iconForge green minus icon

What is Cargo Therapeutics funding to date?

Cargo Therapeutics has raised $131.46MM to date.
Forge green plus iconForge green minus icon

When was Cargo Therapeutics founded?

Cargo Therapeutics was founded in 2021.
Forge green plus iconForge green minus icon

Can you invest in Cargo Therapeutics?

Cargo Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Cargo Therapeutics share pre-IPO?

If you own Cargo Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Cargo Therapeutics a publicly traded company?

Cargo Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Updated on: Nov 15, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.